Skip to content

Ardelyx ARDX Long-Term Debt

Long-Term Debt at other companies

Amgen logo
AmgenAMGN
$51.89B-3.9%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$19.88B-6.4%
XER
Xeris Biopharma Holdings, Inc.XERS
$221.22M+1.6%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$18.94M-36.9%

Other financials

Income statement

See full
Revenue$94.5M+27.5%
Gross profit$89.7M+45.1%
Operating income-$32.8M+9.8%
Net income-$37.6M+8.6%
EPS (diluted)-$0.15+11.8%

Balance sheet

See full
Cash & equivalents$31.2M+1.3%
Total debt$208.3M+34.3%
Total equity$148.6M+2.0%
Total assets$504.5M+23.0%

Cash flow

See full
Operating cash flow-$32.2M+16.2%
CapEx$69.0K-78.8%
Free cash flow-$32.3M+16.7%

Valuation

See full
Market cap$1.53B+79.5%
Enterprise value$1.71B+74.8%
P/S3.6×+1.2×

Profitability

See full
Gross margin92.5%+7.9pp
Operating margin-25.4%
Net margin-13.6%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-39.5%
Debt / equity1.4×+0.3×
Current ratio3.5×-0.6×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebt.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardelyx's long-term debt?
Ardelyx (ARDX) reported long-term debt of $203.52M in Q1 2026.
How has Ardelyx's long-term debt changed year-over-year?
Ardelyx's long-term debt increased by 34.5% year-over-year, from $151.3M to $203.52M.
What is the long-term trend for Ardelyx's long-term debt?
Over 4 years (2021 to 2025), Ardelyx's long-term debt has grown at a 58.3% compound annual growth rate (CAGR), from $32.26M to $202.83M.
What does long-term debt mean?
Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.